Everything below concerns synthetic peptide. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-04-27. Where a claim depends on a specific study, the study is described rather than over-claimed.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
| Property | Value | Notes |
|---|---|---|
| Common synonym | hGH fragment 176-191 | Refers to the C-terminal segment |
| Appearance | White to off-white powder | Typically supplied lyophilized |
| Solubility | Soluble in water and aqueous buffers | Confirm with technical data |
| Typical storage temperature | -20 °C for dry powder | Protect from moisture and light |
| Common analytical method | RP-HPLC with UV detection | Often paired with mass spectrometry |
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
Lotus flowers are widely used as offerings to most female deities, especially Lakshmi, in Hindu temples. Among male deities, lotuses are offered to Vishnu for prosperity and to Shiva for salvation. Garlands made of lotuses are used for adorning deities and lotus petals are used in puja. Lotus seeds are also used in prayer beads. Lotuses are also offered to the Buddha in most Buddhist temples. Lotus is also widely used in Varamala (Hindu wedding garland).
== Niger, Chad, Benin, CAR == Amadou Boubacar Cissé – politician, former prime minister, former Minister of State for Planning, Regional Development, and Community Development, Niger Mamadou Tandja (Fula/Soninke)- former president, Niger Hama Amadou – politician, former prime minister and president of the National Assembly of Niger Amadou Cheiffou – politician, former prime minister of Niger Albadé Abouba – politician, former acting prime minister, Current Minister of State, Minister of Agriculture and Livestock. Niger Bibata Niandou Barry - former Minister of women Affairs. Salifou Modi - former chief of staff, Nigerien Army, Vice President of the National Council for the Safeguard of the Homeland (Military Junta). Aissa Diori - former first lady, Niger Amina Bazindre - former ambassador to romania, Hungary, Germany and Russia. Fatou Djibo - author, first Nigerian woman to drive a car. Bouli Ali Diallo - academic, activist. Abdou Abarry - Nigerian diplomat, former president united nations security council, special representative for Central Africa and Head of the United Nations Regional Office for Central Africa. Ide Oumarou - diplomat, government minister, and journalist, former secretary-general of the Organization of African Unity Abdel Kader Baba-Laddé (or General Baba Laddé or Mahamat Abdoul Kadre) – politician, Chad. Aïchatou Boulama Kané - first female governor of Niamey, former minister of foreign affairs.
== Application == One application of FAIMS is as an additional separation step between the liquid chromatography separation and mass spectrometric analysis in liquid chromatography–mass spectrometry (LC-MS) as used in proteomic studies. It allows for online fractionation of the analyte components to improve detection of peptides in complex samples. LC-MS uses the mass to charge ratio of peptide ions to analyse samples and the resulting spectra are compared to spectral reference libraries. FAIMS can be used to filter out "chemical noise", i.e. compounds whose spectra would interfere with the spectra of the desired compound, either by overlapping with the desired compound's spectra or adding additional peaks to the spectra. It can be used to filter out interfering ions and simultaneously select peptides with charge states that are optimal for analysis. A further advantage of this technique is that it can be used to select for peptide ions that are of low abundance in the sample. Such low abundance ions are often not analysed because of the limitations of the duty cycles of the mass spectrometers. By selectively removing the more abundant ions FAIMS can assist in distinguishing between ions with similar mass to charge ratios and can prevent a more abundant ion from masking the presence of a less abundant ion.
=== SEIR model === For many important infections, there is a significant latency period during which individuals have been infected but are not yet infectious themselves. During this period the individual is in compartment E (for exposed).
Throughout the 1970s, Bakker built a headquarters for PTL in the Carolinas called Heritage Village. Over time, the Bakkers expanded the ministry to include the Heritage USA theme park in Fort Mill, South Carolina, which became the third most successful theme park in the U.S. at the time. Viewer contributions were estimated to exceed $1 million a week, with proceeds to expand the theme park and The PTL Club's mission. Bakker responded to inquiries about his use of mass media by saying: "I believe that if Jesus were alive today, he would be on TV". Two scandals brought down PTL in 1987: Bakker was accused of sexual misconduct by church secretary Jessica Hahn, which led to his resignation, and his alleged illegal misuse of ministry funds eventually led to his imprisonment. Bakker was dismissed as an Assemblies of God minister on May 6, 1987. In 1990, the biographic television movie Fall from Grace, starring Kevin Spacey as Bakker, depicted his rise and fall. On January 18, 2019, ABC's 20/20 aired a two-hour special, entitled Unfaithfully Yours, about the PTL scandal.
Sources: en.wikipedia.org
=== Breakdown (cellulolysis) === Cellulolysis is the process of breaking down cellulose into smaller polysaccharides called cellodextrins or completely into glucose units; this is a hydrolysis reaction. Because cellulose molecules bind strongly to each other, cellulolysis is relatively difficult compared to the breakdown of other polysaccharides. However, this process can be significantly intensified in a proper solvent, e.g. in an ionic liquid. Most mammals have limited ability to digest dietary fibre such as cellulose. Some ruminants like cows and sheep contain certain symbiotic anaerobic bacteria (such as Cellulomonas and Ruminococcus spp.) in the flora of the rumen, and these bacteria produce enzymes called cellulases that hydrolyze cellulose. The breakdown products are then used by the bacteria for proliferation. The bacterial mass is later digested by the ruminant in its digestive system (stomach and small intestine). Horses use cellulose in their diet by fermentation in their hindgut. Some termites contain in their hindguts certain flagellate protozoa producing such enzymes, whereas others contain bacteria or may produce cellulase. The enzymes used to cleave the glycosidic linkage in cellulose are glycoside hydrolases including endo-acting cellulases and exo-acting glucosidases. Such enzymes are usually secreted as part of multienzyme complexes that may include dockerins and carbohydrate-binding modules.
By the mid-1980s, over 65 papers on the topic of coupling reactions involving tin had been published, continuing to explore the substrate scope of this reaction. While initial research in the field focused on the coupling of alkyl groups, most future work involved the much more synthetically useful coupling of vinyl, alkenyl, aryl, and allyl organostannanes to halides. Due to these organotin reagent's stability to air and their ease of synthesis, the Stille reaction became common in organic synthesis.
=== Film adaptation === A film adaptation has been in development hell since 2013, and it was reported on May 25, 2021, that the project is still in development by J.J. Abrams and Bad Robot and the script has been written. As of 2022, J.J. Abrams continued to express interest in bringing Portal to film. In 2026, Kane Parsons also expressed interest in directing a Portal film.
The glucagon receptor is a 62 kDa protein that is activated by glucagon and is a member of the class B G-protein coupled family of receptors (secretin receptor family), coupled to Gs and to a lesser extent Gq, & potentially Gi. Stimulation of the Gs receptor results in the activation of adenylate cyclase, which in turn leads to increased levels of the secondary messengers intracellular cAMP and calcium. In humans, the glucagon receptor is encoded by the GCGR gene. Glucagon receptors are mainly expressed in liver and in kidney with lesser amounts found in heart, adipose tissue, spleen, thymus, adrenal glands, pancreas, cerebral cortex, and gastrointestinal tract.
Such trials in the communist regime were quite common and a typical practice of suppressing the right to free speech. Bosnian politicians used this practice to reaffirm their political opposition to Serbian nationalist tendencies and in particular opposition to the politics of Slobodan Milošević who was trying to revert the constitutional amendments of the 1970s that awarded the Bosniaks the status of a constituent ethnicity. The process also backfired as the Serbian lobby insisted that Bosnia was a "dark nation" where all those who oppose the government will be prosecuted, where Bosnian Muslim communists were prosecuting Muslim believers. That kind of propaganda attracted many Bosnian Muslims to their way of thinking. Others were interpreting the Sarajevo process as a way of removing the political amateurs who could end up disrupting the process of Bosnian independence.
Sources: en.wikipedia.org
=== Books === Decoding Darkness: The Search for the Genetic Causes of Alzheimer's Disease. with Ann B, Parson. New York: Perseus Publishing, 2000. Super Brain: Unleashing the Explosive Power of Your Mind to Maximize Health, Happiness, and Spiritual Well-Being. New York: Harmony Books, Random House, 2012. Super Genes: Unlock the Astonishing Power of Your DNA for Optimum Health and Well-Being. New York: Harmony Books, Random House, 2015. The Healing Self: A Revolutionary New Plan to Supercharge Your Immunity and Stay Well for Life. New York: Harmony, Random House, 2018.
=== Humans === The FPR3 gene was cloned and named based on the similarity of the amino acid sequence which it encodes to that encoded by the gene for FPR1 (see formyl peptide receptor 1 for details) The studies indicated that FPR3 is composed of 352 amino acids and its gene, similar to FPR1, has an intronless open reading frames which encodes a protein with the 7 transmembrane structure of G protein coupled receptors; FPR3 has 69% and 72% amino acid sequence identities with FPR1. All three genes localize to chromosome 19q.13.3 in the order of FPR1 (19q13.410), FPR2 (19q13.3-q13.4), and FPR3 (19q13.3-q13.4) to form a cluster which also includes the genes for another G protein-coupled chemotactic factor receptor, the C5a receptor (also termed CD88) and GPR77, and a second C5a receptor, C5a2 (C5L2), which has the structure of a G protein coupled receptor but fails to couple to G proteins and is of debated function.
In 1997, Mahathir strongly supported Myanmar's inclusion into ASEAN, stating that "we are going to work very hard to get Burma into ASEAN" despite international criticism and American sanctions against the military regime. Mahathir presided as ASEAN chair over Myanmar's admission, playing a key role in ensuring its membership. However, by 2003, Mahathir's stance toward Myanmar had shifted significantly, particularly following the prolonged detention of pro-democracy leader Aung San Suu Kyi. In an interview, he openly stated that if Myanmar's military government continued to refuse Suu Kyi's release, ASEAN might have to consider expelling the country. This marked the first time an ASEAN leader had raised the possibility of Myanmar's expulsion, drawing considerable international attention.
Presumptive testing always precedes analysis of a questioned sample. Most presumptive tests involve a chemical reaction that results in a colour change that is detectable with the plain eye. Thorough documentation of the scene through notes, photographs etc. must be done prior to any presumptive or confirmatory testing in order to maintain chain of custody and avoid contamination. The Griess test and Walker test are two presumptive tests that can be used to determine if a questioned sample contains nitrites. The Walker test is used to determine GSR area on clothing using naphthylamine-sulfanilic acid soaked photograph paper. Red colouration appears when nitrite ions are present. A variant of the Griess test reagent is sulfanilamide and naphthylamine in an acidic medium. The Modified Griess test detects nitrite compounds, which are a by-product of the combustion of gunpowder. Forensic examiners use this test to determine the gun to target distance. This test is performed first because it does not interfere with the later sodium rhodizonate test. The presence of nitrite ions is what triggers the colour change, and therefore we do not consider this test to be indicative of GSR. The sodium rhodizonate test can detect the presence of lead and barium; it results in a red or purple color when lead is present in the tested area, and a reddish-brown colour when exposed to barium. It is an extremely sensitive, specific, and efficient method as it can obtain information on the origin of particulate debris, and it can be done on surfaces or objects.
Sources: en.wikipedia.org
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.
No. It is a shortened peptide fragment, not the full hormone. It does not contain the entire hGH sequence and is studied for different proposed effects.
Regulatory approvals for weight loss are not established in major jurisdictions. Some human trials reported modest changes, but the evidence is limited, and it remains a research compound.
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.